Draft guidance on management of rolling reviews for drug submissions: Performance targets and standards, cancellation (English, HTML)

Draft guidance on management of rolling reviews for drug submissions: Performance targets and standards, cancellation: English HTML file. From Health Canada, updated Sep 2023. View metadata, licence and the direct download on CanQuery.

Format
HTML
Access
Original download only
Publisher-reported update
2023-09-01

The time to complete the screening of a drug submission with a rolling review is 25 days. Once the screening acceptance letter is issued, the review 1 period would begin. The submission would immediately be placed on “rolling review” until Health Canada receives all of the missing information, as indicated in the notice.

Access original file

Data overview

Formats
HTML
File languages
English
Available actions
Access original file

Official sources and licences

Related open data